Bio-Rad Laboratories BIO
NYSE BIO
$380.03 +3.57 (+0.95%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bio-Rad Laboratories (BIO) Gross Margin Growth (3y) (2012 - 2026)

Bio-Rad Laboratories (BIO) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 264.00
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 459.00
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 21.00
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 8.00
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -316.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 73.00
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 90.00
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -3,577.00
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 113.00
10 Bio-Rad Laboratories 10.23 Bn 8.61 Bn 345.80 Mn -10.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.00
Mar 31, 2026 -129.00
Dec 31, 2025 -458.00
Sep 30, 2025 -214.00
Jun 30, 2025 -416.00
Mar 31, 2025 -523.00
Dec 31, 2024 -334.00
Sep 30, 2024 -365.00
Jun 30, 2024 -41.00
Mar 31, 2024 -175.00
Dec 31, 2023 -448.00
Sep 30, 2023 -363.00
Jun 30, 2023 -135.00
Mar 31, 2023 -198.00
Dec 31, 2022 147.00
Sep 30, 2022 -3.00
Jun 30, 2022 340.00
Mar 31, 2022 122.00
Dec 31, 2021 66.00
Sep 30, 2021 584.00